Cargando…

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting

Glioblastoma multiforme (GBM) is the most common and lethal form of brain tumor. The prognosis for patients remains poor, despite the combination of new preoperative and intraoperative neuroimaging, radical surgery, and recent advances in radiotherapy and chemotherapy. To improve GBM therapy and pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samec, Neja, Jovcevska, Ivana, Stojan, Jure, Zottel, Alja, Liovic, Mirjana, Myers, Michael P., Muyldermans, Serge, Šribar, Jernej, Križaj, Igor, Komel, Radovan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915116/ https://www.ncbi.nlm.nih.gov/pubmed/29707108 http://dx.doi.org/10.18632/oncotarget.24629

Ejemplares similares

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
por: Zottel, Alja, et al.
Publicado: (2020)

Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates
por: Vidak, Marko, et al.
Publicado: (2018)

Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles
por: Colja, Sara, et al.
Publicado: (2023)

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas
por: Jovčevska, Ivana, et al.
Publicado: (2019)

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
por: Porčnik, Andrej, et al.
Publicado: (2021)

Non-animal glioblastoma models for personalized treatment
por: Zottel, Alja, et al.
Publicado: (2023)

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo
por: Zottel, Alja, et al.
Publicado: (2023)

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
por: Zottel, Alja, et al.
Publicado: (2020)

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020)

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
por: Zottel, Alja, et al.
Publicado: (2020)

Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
por: Jovčevska, Ivana, et al.
Publicado: (2017)

The Therapeutic Potential of Nanobodies
por: Jovčevska, Ivana, et al.
Publicado: (2019)

TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers
por: Jovčevska, Ivana, et al.
Publicado: (2014)

Editorial: Nanobody-based cancer immunotherapy and immunoimaging
por: Jafari, Mahdie, et al.
Publicado: (2023)

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma
por: Sorokin, Maxim, et al.
Publicado: (2021)

Current Technologies for RNA-Directed Liquid Diagnostics
por: Martinez-Dominguez, Maria Victoria, et al.
Publicado: (2021)

Intestinal Cell Barrier Function In Vitro Is Severely Compromised by Keratin 8 and 18 Mutations Identified in Patients with Inflammatory Bowel Disease
por: Zupancic, Tina, et al.
Publicado: (2014)

Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer
por: Chanier, Timothée, et al.
Publicado: (2019)

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
por: Zottel, Alja, et al.
Publicado: (2019)

Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
por: Yu, Sheng, et al.
Publicado: (2021)

Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma
por: Ruiz-López, Eduardo, et al.
Publicado: (2022)

OligoPrime: An Information System for Oligonucleotide Management
por: Ravnik, Šimen, et al.
Publicado: (2021)

Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas
por: Zolotovskaia, Marianna, et al.
Publicado: (2021)

Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells
por: Liovic, Mirjana, et al.
Publicado: (2012)

A guide to: generation and design of nanobodies
por: Muyldermans, Serge
Publicado: (2020)

Secreted Phospholipases A(2) - not just Enzymes: Revisited
por: Ivanušec, Adrijan, et al.
Publicado: (2022)

Oleic Acid Metabolism via a Conserved Cytochrome P450 System-Mediated ω-Hydroxylation in the Bark Beetle-Associated Fungus Grosmannia clavigera
por: Novak, Metka, et al.
Publicado: (2015)

The Phospholipase Activity of Ammodytoxin, a Prototype Snake Venom β-Neurotoxin, Is Not Obligatory for Cell Internalisation and Translocation to Mitochondria
por: Ivanušec, Adrijan, et al.
Publicado: (2022)

Application of Single-Domain Antibodies (“Nanobodies”) to Laboratory Diagnosis
por: Pillay, Tahir S., et al.
Publicado: (2021)

3D multiple immunoimaging using whole male organs in rice
por: Araki, Saori, et al.
Publicado: (2022)

Multiparametric Immunoimaging Maps Inflammatory Signatures in Murine Myocardial Infarction Models
por: Maier, Alexander, et al.
Publicado: (2023)

Nanobodies and recombinant binders in cell biology
por: Helma, Jonas, et al.
Publicado: (2015)

Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy
por: Hu, Yaozhong, et al.
Publicado: (2017)

Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast
por: Vogelsang, Matjaz, et al.
Publicado: (2009)

Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles
por: Krapež, Gloria, et al.
Publicado: (2022)

Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment
por: Sadeghnezhad, Golnaz, et al.
Publicado: (2019)

TUFM-knockdown inhibits the migration and proliferation of gastrointestinal stromal tumor cells
por: Weng, Xiaoyuan, et al.
Publicado: (2020)

Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers
por: Arezumand, Roghaye, et al.
Publicado: (2017)

On the Role of Protein Disulfide Isomerase in the Retrograde Cell Transport of Secreted Phospholipases A(2)
por: Oberčkal, Jernej, et al.
Publicado: (2015)

The neurotoxic secreted phospholipase A(2) from the Vipera a. ammodytes venom targets cytochrome c oxidase in neuronal mitochondria
por: Šribar, Jernej, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iq6042266a8bfcrtf87lqsvh3j